CClinicalTrials.gg
Not yet recruitingNCT07866170OLV-VENTUpdated Oct 8, 2026

Comparison of Different Ventilation Modes in Video-Assisted Thoracoscopic Lung Resection

An observational study in One-lung Ventilation (OLV) and Video-assisted Thoracis Surgery (VATS), sponsored by Ankara Ataturk Sanatorium Training and Research Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Ankara Ataturk Sanatorium Training and Research Hospital · Observational

Updated Oct 8, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

One-lung ventilation (OLV) is required for video-assisted thoracoscopic surgery (VATS) lung resection, but it exposes the dependent lung to atelectasis, high driving pressures, and oxidative stress, and is associated with postoperative pulmonary complications. Volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV) are the conventional modes used during OLV. Flow-controlled ventilation (FCV) is a newer mode that delivers a constant gas flow during both inspiration and expiration through a narrow-bore endotracheal tube, and has been proposed to improve gas distribution and reduce mechanical stress on the lung.

This prospective observational study evaluates oxygenation and respiratory mechanics in adult patients undergoing elective VATS lung resection under OLV. The ventilation mode used for each patient is determined by the attending anaesthesiologist as part of routine clinical care, independently of the study; investigators do not participate in any aspect of patient management and collect data through observation only. Patients are grouped according to the mode used in clinical practice (FCV, VCV, or PCV).

The primary outcome is arterial oxygenation (PaO₂) at 30 minutes of OLV. Secondary outcomes include dynamic lung compliance, driving pressure, mechanical power, and haemodynamic parameters recorded at predefined intervals. A total of 120 patients (ASA I-III, GOLD stage 1-2) are planned for enrolment.

02

Conditions studied

  • One-lung Ventilation (OLV)
  • Video-assisted Thoracis Surgery (VATS)

Keywords

  • Volume-Controlled Ventilation
  • Pressure-Controled Ventilation
  • Flow-Controlled Ventilation
  • Driving Pressure
  • Postoperative Complications
  • Mechanical Power
03

In context

Postoperative Complications

1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.

This study's planned enrollment of 120 is below the median of 254 across 519 observational studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

Ankara Ataturk Sanatorium Training and Research Hospital is the lead sponsor of 33 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged 18 years and older, ASA physical status I-III, scheduled for elective lung resection by video-assisted thoracoscopic surgery (VATS) with planned one-lung ventilation under total intravenous anesthesia at a single tertiary center. Patients are assigned to one of three groups according to the ventilation mode selected by the attending anesthesiologist (FCV, VCV, or PCV); no randomization is performed.

Inclusion criteria

  • -Age 18 years and older
  • American Society of Anesthesiologists (ASA) physical status I, II, or III
  • Scheduled for elective lung resection by video-assisted thoracoscopic surgery (VATS)
  • Planned one-lung ventilation
  • GOLD 2026 group 1 or group 2
  • Planned total intravenous anesthesia (TIVA)
  • Willing to participate and provides written informed consent

Exclusion criteria

Exclusion Criteria:

  • ASA physical status IV or older
  • Emergency surgery
  • Previous neoadjuvant chemotheraphy or radiotherapy
  • GOLD 2026 group 3 or group 4
  • Pneumothorax, pleural effusion or interstitial lung disease
  • One-lung ventilation cannot be clinically maintained
  • Planned thoracotomy
  • Incomplete data
  • Refusal to participate
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Flow-Controlled Ventilation

    Patients ventilated with flow-controlled ventilation during one-lung ventilation, as selected by the attending anaesthesiologist

  • Volume-Controlled Ventilation

    Patients ventilated with volume-controlled ventilation during one-lung ventilation, as selected by the attending anaesthesiologist

  • Pressure-Controlled Ventilation

    Patients ventilated with pressure-controlled ventilation during one-lung ventilation, as selected by the attending anaesthesiologist

06

What researchers measure

Primary outcomes

  1. Partial pressure of oxygen (PaO₂) during one-lung ventilation

    PaO₂ in mmHg obtained from arterial blood gas analysis of a radial artery sample, measured at 30 minutes after the initiation of one-lung ventilation, with FiO₂ recorded simultaneously

    Time frame: 30-minutes after initiation of one-lung ventilation

Secondary outcomes

  1. PaO₂/FiO₂ ratio

    Ratio of the partial pressure of arterial oxygen to the inspired oxygen fraction, calculated from arterial blood gas analysis.

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  2. Partial pressure of arterial carbon dioxide (PaCO₂)

    PaCO₂ in mmHg obtained from arterial blood gas analysis.

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  3. Dynamic Compliance

    Dynamic compliance obtained from ventilator readings

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  4. Pleteau Pressure

    Pleteau pressure obtained from ventilator readings

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  5. Driving Pressure

    Driving pressure obtained form ventilator settings

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  6. Mechanical Power

    Mechanical power (J/min) obtained and calculated form ventilator settings

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  7. Peak Inspiratory Pressure

    Peak inspiratory pressure obtained form ventilator settings

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  8. Mean Airway Pressure

    Mean airway pressure obtained and calculated form ventilator readings

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  9. Systolic Arterial Pressure

    Systolic arterial pressure (mmHg) measured by invasive arterial monitoring

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  10. Diastolic Arterial Pressure

    Diastolic arterial pressure (mmHg) measured by invasive arterial monitoring

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  11. Heart Rate

    Heart rate (beats per minute) measured by continuous electrocardiographic monitoring

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  12. Mean Arterial Pressure

    Mean arterial pressure (mmHg) measured by invasive arterial monitoring

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  13. Peripheral Oxygen Saturation

    Peripheral oxygen saturation (SpO₂, %), measured by pulse oximetry

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  14. pH

    pH obtained by arterial blood gas analysis

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  15. End-tidal CO₂

    End-tidal CO₂ (mmHg), measured by capnography

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  16. Tidal Volume

    Tidal volume (mL), obtained from ventilator readings

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  17. PEEP

    PEEP (cmH₂O), obtained from ventilator readings

    Time frame: 0 and 30 minutes after initiation of one-lung ventilation, and immediately before resumption of two-lung ventilation, up to 240 minutes

  18. Postoperative pulmonary complications

    Composite incidence of respiratory infection, respiratory failure, bronchospasm, atelectasis, pleural effusion, pneumothorax and aspiration pneumonia, assessed during the postoperative hospital stay.

    Time frame: From end of surgery through postoperative day 7 or hospital discharge, whichever occurs first

  19. Lenght of stay and readmission

    Duration of intensive care stay, ward stay, total hospital stay and hospital readmission after discharge.

    Time frame: From date of surgery to date of hospital discharge, up to 30 days

07

Study locations

1 site
  • Ankara Ataturk Sanatoryum Education and Research Hospital
    Ankara, 06290, Turkey (Türkiye)
08

References and documents

Publications

  • Van Oosten JP, Francovich JE, Somhorst P, van der Zee P, Endeman H, Gommers DAMPJ, Jonkman AH. Flow-controlled ventilation decreases mechanical power in postoperative ICU patients. Intensive Care Med Exp. 2024 Mar 19;12(1):30. doi: 10.1186/s40635-024-00616-9. PubMed 38502268 ↗
  • Uhlig C, Neto AS, van der Woude M, Kiss T, Wittenstein J, Shelley B, Scholes H, Hiesmayr M, Vidal Melo MF, Sances D, Coskunfirat N, Pelosi P, Schultz M, Gama de Abreu M; LAS VEGAS# investigators, Protective Ventilation Network (PROVEnet), Clinical Trial Network of the European Society of Anaesthesiology. Intraoperative mechanical ventilation practice in thoracic surgery patients and its association with postoperative pulmonary complications: results of a multicenter prospective observational study. BMC Anesthesiol. 2020 Jul 22;20(1):179. doi: 10.1186/s12871-020-01098-4. PubMed 32698775 ↗
  • Li XF, Jin L, Yang JM, Luo QS, Liu HM, Yu H. Effect of ventilation mode on postoperative pulmonary complications following lung resection surgery: a randomised controlled trial. Anaesthesia. 2022 Nov;77(11):1219-1227. doi: 10.1111/anae.15848. Epub 2022 Sep 6. PubMed 36066107 ↗
  • Wittenstein J, Scharffenberg M, Ran X, Keller D, Michler P, Tauer S, Theilen R, Kiss T, Bluth T, Koch T, Gama de Abreu M, Huhle R. Comparative effects of flow vs. volume-controlled one-lung ventilation on gas exchange and respiratory system mechanics in pigs. Intensive Care Med Exp. 2020 Dec 18;8(Suppl 1):24. doi: 10.1186/s40635-020-00308-0. PubMed 33336305 ↗
  • Abram J, Spraider P, Martini J, Velik-Salchner C, Dejaco H, Augustin F, Putzer G, Hell T, Barnes T, Enk D. Flow-controlled versus pressure-controlled ventilation in thoracic surgery with one-lung ventilation - A randomized controlled trial. J Clin Anesth. 2025 Apr;103:111785. doi: 10.1016/j.jclinane.2025.111785. Epub 2025 Feb 27. PubMed 40020438 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07866170
Lead sponsor
Ankara Ataturk Sanatorium Training and Research Hospital
Responsible party
Yenal Zorlu (Resident Physician in Anesthesiology, Ankara Ataturk Sanatorium Training and Research Hospital) — Principal investigator
First posted
Oct 8, 2026
Start date
Oct 12, 2026 (estimated)
Primary completion
Sep 3, 2027 (estimated)
Completion
Sep 3, 2027 (estimated)
Last update
Oct 8, 2026

Study contacts

Yenal ZORLU
principal investigator · Ankara Ataturk Sanatorium Training and Research Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion